IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel

10.1038/ncomms9746

Saved in:

Bibliographic Details
Main Authors:	Wee, Z.N, Yatim, S.M.J.M, Kohlbauer, V.K, Feng, M, Goh, J.Y, Yi, B, Lee, P.L, Zhang, S, Wang, P.P, Lim, E, Tam, W.L, Cai, Y, Ditzel, H.J, Hoon, D.S.B, Tan, E.Y, Yu, Q
Other Authors:	PHYSIOLOGY
Format:	Article
Published:	Nature Publishing Group 2020
Subjects:	apoptosis cancer gene expression hormone rabies secretion tumor antineoplastic agent interleukin 1 receptor associated kinase IRAK1 protein, human paclitaxel animal antagonists and inhibitors Breast Neoplasms cell proliferation drug effects drug resistance enzymology female genetics human metabolism metastasis mouse pathology phosphorylation SCID mouse tumor cell line Animals Antineoplastic Agents, Phytogenic Apoptosis Cell Line, Tumor Cell Proliferation Drug Resistance, Neoplasm Female Humans Interleukin-1 Receptor-Associated Kinases Mice Mice, SCID Neoplasm Metastasis Paclitaxel Phosphorylation
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/180422
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-180422
record_format	dspace
spelling	sg-nus-scholar.10635-1804222024-11-09T14:02:04Z IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel Wee, Z.N Yatim, S.M.J.M Kohlbauer, V.K Feng, M Goh, J.Y Yi, B Lee, P.L Zhang, S Wang, P.P Lim, E Tam, W.L Cai, Y Ditzel, H.J Hoon, D.S.B Tan, E.Y Yu, Q PHYSIOLOGY MECHANOBIOLOGY INSTITUTE BIOCHEMISTRY apoptosis cancer gene expression hormone rabies secretion tumor antineoplastic agent interleukin 1 receptor associated kinase IRAK1 protein, human paclitaxel animal antagonists and inhibitors apoptosis Breast Neoplasms cell proliferation drug effects drug resistance enzymology female genetics human metabolism metastasis mouse pathology phosphorylation SCID mouse tumor cell line Animals Antineoplastic Agents, Phytogenic Apoptosis Breast Neoplasms Cell Line, Tumor Cell Proliferation Drug Resistance, Neoplasm Female Humans Interleukin-1 Receptor-Associated Kinases Mice Mice, SCID Neoplasm Metastasis Paclitaxel Phosphorylation 10.1038/ncomms9746 Nature Communications 6 8746 2020-10-26T08:54:57Z 2020-10-26T08:54:57Z 2015 Article Wee, Z.N, Yatim, S.M.J.M, Kohlbauer, V.K, Feng, M, Goh, J.Y, Yi, B, Lee, P.L, Zhang, S, Wang, P.P, Lim, E, Tam, W.L, Cai, Y, Ditzel, H.J, Hoon, D.S.B, Tan, E.Y, Yu, Q (2015). IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel. Nature Communications 6 : 8746. ScholarBank@NUS Repository. https://doi.org/10.1038/ncomms9746 2041-1723 https://scholarbank.nus.edu.sg/handle/10635/180422 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Nature Publishing Group Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	apoptosis cancer gene expression hormone rabies secretion tumor antineoplastic agent interleukin 1 receptor associated kinase IRAK1 protein, human paclitaxel animal antagonists and inhibitors apoptosis Breast Neoplasms cell proliferation drug effects drug resistance enzymology female genetics human metabolism metastasis mouse pathology phosphorylation SCID mouse tumor cell line Animals Antineoplastic Agents, Phytogenic Apoptosis Breast Neoplasms Cell Line, Tumor Cell Proliferation Drug Resistance, Neoplasm Female Humans Interleukin-1 Receptor-Associated Kinases Mice Mice, SCID Neoplasm Metastasis Paclitaxel Phosphorylation
spellingShingle	apoptosis cancer gene expression hormone rabies secretion tumor antineoplastic agent interleukin 1 receptor associated kinase IRAK1 protein, human paclitaxel animal antagonists and inhibitors apoptosis Breast Neoplasms cell proliferation drug effects drug resistance enzymology female genetics human metabolism metastasis mouse pathology phosphorylation SCID mouse tumor cell line Animals Antineoplastic Agents, Phytogenic Apoptosis Breast Neoplasms Cell Line, Tumor Cell Proliferation Drug Resistance, Neoplasm Female Humans Interleukin-1 Receptor-Associated Kinases Mice Mice, SCID Neoplasm Metastasis Paclitaxel Phosphorylation Wee, Z.N Yatim, S.M.J.M Kohlbauer, V.K Feng, M Goh, J.Y Yi, B Lee, P.L Zhang, S Wang, P.P Lim, E Tam, W.L Cai, Y Ditzel, H.J Hoon, D.S.B Tan, E.Y Yu, Q IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
description	10.1038/ncomms9746
author2	PHYSIOLOGY
author_facet	PHYSIOLOGY Wee, Z.N Yatim, S.M.J.M Kohlbauer, V.K Feng, M Goh, J.Y Yi, B Lee, P.L Zhang, S Wang, P.P Lim, E Tam, W.L Cai, Y Ditzel, H.J Hoon, D.S.B Tan, E.Y Yu, Q
format	Article
author	Wee, Z.N Yatim, S.M.J.M Kohlbauer, V.K Feng, M Goh, J.Y Yi, B Lee, P.L Zhang, S Wang, P.P Lim, E Tam, W.L Cai, Y Ditzel, H.J Hoon, D.S.B Tan, E.Y Yu, Q
author_sort	Wee, Z.N
title	IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
title_short	IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
title_full	IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
title_fullStr	IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
title_full_unstemmed	IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
title_sort	irak1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
publisher	Nature Publishing Group
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/180422
_version_	1821232466927550464

IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel

Similar Items